Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial

Nutrition Research

Volumn 28, Issue 1, 2008, Pages 1-5

  Diop, Laurent ^a   Guillou, Sonia ^b   Durand, Henri ^c  

^a Savoir Faire and Cie   (France)

^b Proclaim   (France)

^c LALLEMAND SAS   (France)

Author keywords

Bifidobacterium; Gastrointestinal symptoms; Humans; Lactobacillus; Probiotics; Stress; Visceral pain

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPHAGIA; FEMALE; FLATULENCE; GAS EMBOLISM; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA AND VOMITING; NORMAL HUMAN; PRIORITY JOURNAL; STRESS; XEROSTOMIA;

ABDOMINAL PAIN; ADOLESCENT; ADULT; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; NAUSEA; PLACEBOS; PROBIOTICS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS;

EID: 38049028249     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.10.001     Document Type: Article

References (35)

1. Monnikes H., Tebbe J.J., Hildebrandt M., Arck P., Osmanoglou E., Rose M., et al. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 19 (2001) 201-211
2. Roth B., and Robbins D. Mindfulness-based stress reduction and health-related quality of life: findings from a bilingual inner-city patient population. Psychosom Med 66 (2004) 113-123
3. Maddux R.E., Delrahim K.K., and Rapaport M.H. Quality of life in geriatric patients with mood and anxiety disorders. CNS Spectr 8 (2003) 35-47
4. Kamm M.A. The role of psychosocial factors in functional gut disease. Eur J Surg Suppl (1998) 37-40
5. Mayer E.A. The neurobiology of stress and gastrointestinal disease. Gut 47 (2000) 861-869
6. Valori R.M., Kumar D., and Wingate D.L. Effects of different types of stress and of "prokinetic" drugs on the control of the fasting motor complex in humans. Gastroenterology 90 (1986) 1890-1900
7. Narducci F., Snape Jr. W.J., Battle W.M., London R.L., and Cohen S. Increased colonic motility during exposure to a stressful situation. Dig Dis Sci 30 (1985) 40-44
8. Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gut 51 Suppl 1 (2002) i29-i33
9. Mertz H., Morgan V., Tanner G., Pickens D., Price R., Shyr Y., et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118 (2000) 842-848
10. Creed F., and Guthrie E. Psychological treatments of the irritable bowel syndrome: a review. Gut 30 (1989) 1601-1609
11. Creed F., Ratcliffe J., Fernandez L., Tomenson B., Palmer S., Rigby C., et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134 (2001) 860-868
12. Bennett E.J., Tennant C.C., Piesse C., Badcock C.A., and Kellow J.E. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 43 (1998) 256-261
13. Jiang T., and Savaiano D.A. Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci 42 (1997) 2370-2377
14. Ouwehand A.C., Lagstrom H., Suomalainen T., and Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46 (2002) 159-162
15. Durand H., and Diop L. Probiotics and intestinal health benefits. Medika 32 (2006) 146-153
16. Ait-Belgnaoui A., Han W., Lamine F., Eutamene H., Fioramonti J., Bueno L., et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 55 (2006) 1090-1094
17. Kamiya T., Wang L., Forsythe P., Goettsche G., Mao Y., Wang Y., et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55 (2006) 191-196
18. Hollis S., and Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Bmj 319 (1999) 670-674
19. Lewis R.J., and Bessen H.A. Statistical concepts and methods for the reader of clinical studies in emergency medicine. J Emerg Med 9 (1991) 221-232
20. Borriello S.P., Hammes W.P., Holzapfel W., Marteau P., Schrezenmeir J., Vaara M., et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36 (2003) 775-780
21. Ishibashi N., and Yamazaki S. Probiotics and safety. Am J Clin Nutr 73 (2001) 465S-470S
22. Mawdsley J.E., and Rampton D.S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54 (2005) 1481-1491
23. Soderholm J.D., and Perdue M.H. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 280 (2001) G7-G13
24. Bradesi S., Eutamene H., Garcia-Villar R., Fioramonti J., and Bueno L. Acute and chronic stress differently affect visceral sensitivity to rectal distension in female rats. Neurogastroenterol Motil 14 (2002) 75-82
25. Gonlachanvit S., Rhee J., Sun W.M., and Chey W.D. Effect of acute acoustic stress on anorectal function sensation in healthy human. Neurogastroenterol Motil 17 (2005) 222-228
26. Sullivan A., and Nord C.E. Probiotics and gastrointestinal diseases. J Intern Med 257 (2005) 78-92
27. Goossens D., Jonkers D., Stobberingh E., van den Bogaard A., Russel M., and Stockbrugger R. Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol Suppl (2003) 15-23
28. Verdu E.F., Bercik P., Verma-Gandhu M., Huang X.X., Blennerhassett P., Jackson W., et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55 (2006) 182-190
29. Sen S., Mullan M.M., Parker T.J., Woolner J.T., Tarry S.A., and Hunter J.O. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 47 (2002) 2615-2620
30. Niedzielin K., Kordecki H., and Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13 (2001) 1143-1147
31. Kim H.J., Camilleri M., McKinzie S., Lempke M.B., Burton D.D., Thomforde G.M., et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17 (2003) 895-904
32. Kim H.J., Vazquez Roque M.I., Roque I., Camilleri M., Stephens D., Burton D.D., et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17 (2005) 687-696
33. O'Sullivan M.A., and O'Morain C.A. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 32 (2000) 294-301
34. Niv E., Naftali T., Hallak R., and Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome-a double blind, placebo-controlled, randomized study. Clin Nutr 24 (2005) 925-931
35. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005) 541-551